3/22/2007 UCSD Cancer Researcher Richard D. Kolodner Honored with Landon - AACR Prize
for Basic Cancer Research Scientists whose discoveries have led to fundamental advances in the science and treatment of cancer are the recipients of two prestigious international prizes offered by the Kirk A. and Dorothy P. Landon Foundation and the American Association for C...
Swiss Bridge Award for Research in Cancer Funding
for basic cancer research, genetics and epidemiology, psycho - oncology and prevention research (total support approximating CHF 500,000).
Not exact matches
The President himself set a high bar
for science funding when he at various times pledged to double
basic research, physical science, and
cancer research funding on the campaign trail.
Delegates included those interested in all aspects of lung
cancer, including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists,
basic research scientists, with special sessions
for nurses, allied health professionals and advocacy members.
Focusing on
basic research for the functional regulation of innate and adaptive immunity and on translational
research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative
research and exploration, and is becoming a rising star in the international immunology community.
«We are looking to optimize the combinations of targeted therapies and the scheduling of those therapies so we can improve tumor shrinkage and minimize potential toxicities
for a patient,» said Andrew Aplin, PhD, Associate Director
for Basic Research and the Program Leader
for Cancer Cell Biology and Signaling (CCBS) in the NCI - designated Sidney Kimmel
Cancer Center at Jefferson Health.
This question was answered in
research published in the current online edition of Molecular Cell, by senior author Eileen White, PhD, associate director
for basic science at the
Cancer Institute of New Jersey, and colleagues.
«
Research into
basic workings of immune system points to way of improving therapies
for cancer: Differences in wiring of «exhausted» and effective T cells indicate possible gene - editing targets.»
Researchers at the Institute
for Basic Science (IBS) in South Korea have succeeded in developing the world's first technology to control specific protein functions in living cells by using lights, which may be useful in future
cancer cell
research.
Now researchers working on canine
cancer have an authenticated resource similar to what's available for human cancers,» says Daniel L. Gustafson, PhD, CU Cancer Center investigator and director for basic research at the Flint Animal Cancer C
cancer have an authenticated resource similar to what's available
for human
cancers,» says Daniel L. Gustafson, PhD, CU
Cancer Center investigator and director for basic research at the Flint Animal Cancer C
Cancer Center investigator and director
for basic research at the Flint Animal
Cancer C
Cancer Center.
Greenberg is also an associate investigator at the Abramson Family
Cancer Research Institute and director of
Basic Science
for the Basser Center
for BRCA.
2001 - present, Associate Director
for Basic Research, City of Hope Comprehensive
Cancer Center, Duarte, CA
«What we have to do as a nation is to realise that
basic research has had enormous benefits,» says Harold Varmus, a Nobel prizewinner
for his work on
cancer genetics and a member of the panel.
In its twenty years of operation, the NRSA program has made it possible
for many thousands of talented individuals in the
basic biomedical, behavioral, and clinical sciences to sharpen their
research skills and to apply those skills to topics of special concern to the nation, such as aging, hypertension, the genetic basis of disease, acquired immune deficiency syndrome (AIDS),
cancer, environmental toxicology, nutrition and health, and substance abuse.
Our researchers in the Center
for Childhood
Cancer are conducting basic science, translational and clinical research geared toward finding a cure for childhood cancer and improving the toxicity of current treat
Cancer are conducting
basic science, translational and clinical
research geared toward finding a cure
for childhood
cancer and improving the toxicity of current treat
cancer and improving the toxicity of current treatments.
«It was extremely exciting to get this award as it will provide my lab both the resources and the stability
for our ongoing efforts,» says Shaw, who is also the director of the Salk
Cancer Center, which is one of just seven NCI - designated
Basic Research Cancer Centers in the country.
Blackburn was elected president of the American Association
for Cancer Research and is a recipient of the Albert Lasker
Basic Medical
Research Award, among many other awards.
The network will contribute to extensive databases with
cancer patient information, such as medical history,
cancer tissue and DNA, that can be used
for basic research and clinical trials.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine, Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech company whose mission is to develop new therapies against
cancer and aging - related disease; Biopolo, a not
for profit company involved in the technological transfer of
basic research to the productive system.
Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging
basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities
for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in
cancer and their potential therapeutic manipulation.
The New Investigator Committee has a broad remit spanning
basic and translational
cancer research, responsible
for a number of funding schemes to support the
cancer research leaders of tomorrow at all stages of their careers.
June 2013 — Byron Lee, MD, PhD, who completed his
research year as part of the Urology residency program in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award in basic science for a paper published in Cancer R
research year as part of the Urology residency program in the Genomic Medicine Institute under the mentorship of Angela Ting, PhD, won a second place Lower Memorial Award in
basic science
for a paper published in
Cancer ResearchResearch.
Location: NC1 - 202 Title: «Brain Metastases - Our Advances and Failures» The Department of Cellular and Molecular Medicine welcomes guest speaker Dr. Paul R. Lockman, Professor and Chair
Basic Pharmaceutical Sciences, Associate Center Director
for Translational
Research, West Virginia University
Cancer Institute.
Research ranges from basic molecular and genetic studies to epidemiological and clinical research on cancer prevention, early diagnosis, molecular characteristics of the cancer process and new treatments for cancer using drugs and radio
Research ranges from
basic molecular and genetic studies to epidemiological and clinical
research on cancer prevention, early diagnosis, molecular characteristics of the cancer process and new treatments for cancer using drugs and radio
research on
cancer prevention, early diagnosis, molecular characteristics of the
cancer process and new treatments
for cancer using drugs and radiotherapy.
Personalised medicine is becoming relevant in the treatment of lung
cancer [42, 43] and may have relevance
for other lung diseases, like pulmonary fibrosis, asthma and pulmonary hypertension, but disease - related
basic research aimed at searching
for biomarkers is needed to achieve personalised and patient - specific treatments
for lung diseases.
This department provides clinicians and researchers with human and technological resources enabling the development of application - oriented projects, with the objective of improving care
for cancer patients (assessment and validation of diagnostic, prognostic and patient support tools, as well as development of biomedical devices or therapeutic approaches resulting from
basic research).
The Thoracic Program provides pilot funding
for the conduct of
basic, translational, or clinical
research on the cause, prevention, detection, control, or treatment of lung
cancer.
Grant support: Chinese National Key Program
for Basic Research 973, Chinese National High Tech Program 863 (2006AA02Z19A), National Natural Science Foundation of China (30570778 and 30670882), «Shu Guang» Program of Shanghai Municipal Commission
for Education (03SG37), and Samuel Waxman
Cancer Research Foundation.
Vanderbilt - Ingram
Cancer Center regularly solicits applications for pilot funding to support basic, translational, clinical or collaborative cancer res
Cancer Center regularly solicits applications
for pilot funding to support
basic, translational, clinical or collaborative
cancer res
cancer research.
This tutorial consists of nine informal «blackboard» sessions of one to one and a half hours in length, during which program faculty will discuss with the new trainees the
basic science principles essential
for translational
cancer research.
He is the recipient of the New York City Mayor's Award
for Excellence in Science and Technology, the American Association of Immunologists - Invitrogen Meritorious Career Award, the Ross Prize in Molecular Medicine, the Vilcek Prize in Biomedical Science, and the William B. Coley Award
for Distinguished
Research in
Basic Immunology from the
Cancer Research Institute.
He has already joined Roger Gomis» Growth Control and
Cancer Metastasis group, where he will perform the
basic research for his project.
The core is located at the
Basic Science
Research Building of the MD Anderson Cancer Center and is fully equipped for molecular biology r
Research Building of the MD Anderson
Cancer Center and is fully equipped
for molecular biology
researchresearch.
Science Committee is responsible
for the oversight, development, review, funding and management of a portfolio of
basic and translational
cancer research Programme and Project Awards.
Napoleone Ferrara, senior deputy director
for basic sciences at the University of California, San Diego Moores
Cancer Center, has been chosen as one of the recipients of the $ 3 million Breakthrough Prize, a newly created award, and the richest honor of its kind in the history of scientific
research.
She was recently awarded the Amiya Patnaik Memorial Award
for Most Outstanding Resident
Basic Science
Research at the 2014 Veterinary
Cancer Society conference
for this work.